首页> 外文期刊>Journal of Labelled Compounds and Radiopharmaceuticals >Radiosynthesis of 1 -[~18F]fluoroethyl-beta-D-lactose ([~18F]-FEL) for early detection of pancreatic carcinomas with PET
【24h】

Radiosynthesis of 1 -[~18F]fluoroethyl-beta-D-lactose ([~18F]-FEL) for early detection of pancreatic carcinomas with PET

机译:放射性合成1- [〜18F]氟乙基-β-D-乳糖([〜18F] -FEL)的PET早期检测

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: The hepatocellular carcinoma-intestine-pancreas and pancreatitis-associated proteins, also known as lactose-binding protein, is upregulated in peritumoral pancreatic tissue. Previously, we reported ethyl-beta-D-galactopyranosyl-(1,4')-2'-deoxy-2'-[~18F]fluoro-beta-D-glucopyranoside (Et-[~18F]-FDL), a radiofluorinated lactose analog for positron emission tomography (PET) of small pancreatic carcinomas in mice. However, synthesis of the precursor for Et-[~18F]-FDL involves 11 steps, which is quite lengthy, and produces overall low yields. Here, we report on synthesis and radiolabeling of another analog of lactose, the 1'-[~18F]fluoroethyl-beta-D-lactose for PET imaging of pancreatic carcinomas. Methods: Two precursor compounds, 1'-bromoethyl-2',3',6',2,3,4,6-hepta-0-acetyl-beta-D-lactose 4, and 1'-p-toluenesulfonylethyl-2',3',6',2,3,4,6-hepta-O-acetyl-beta-D-lactose 5, were synthesized in two and three steps, respectively; then, cold fluorination and radiofluorination of these precursors were performed. The reaction mixture was passed through a silica gel Sep-pack cartridge, eluted with EtOAc, and the 1-[~18F]fluoroethyl-2,3,6',2,3,4,6-hepta-O-acetyl-beta-D-lactose ([~18F]-6) purified by HPLC. After hydrolysis of the protecting groups, the 1'-[ F]fluoroethyl-beta-D-lactose [~18F]-7 was neutralized, diluted with saline, filtered through a sterile Millipore filter, and analyzed by radio-TLC. Results: The average decay-corrected radiochemical yield was 9% (n = 7) with > 99% radiochemical purity and specific activity of 55.5 GBq/mumol. Conclusion: A new analog of lactose, 1'-[~18F]fluoroethyl-beta-D-lactose, has been synthesized in good yields, with high purity and high specific activity suitable for PET imaging of early pancreatic carcinomas.
机译:简介:肝细胞癌-肠-胰腺和胰腺炎相关蛋白,也称为乳糖结合蛋白,在肿瘤周围胰腺组织中上调。以前,我们报道了乙基-β-D-吡喃半乳糖基-(1,4')-2'-脱氧-2'-[〜18F]氟-β-D-吡喃葡萄糖苷(Et- [〜18F] -FDL),放射性氟化乳糖类似物用于小鼠小胰腺癌的正电子发射断层扫描(PET)。然而,Et- [〜18F] -FDL的前体的合成涉及11个步骤,这相当长,而且总收率较低。在这里,我们报告了乳糖的另一类似物1'-[〜18F]氟乙基-β-D-乳糖的合成和放射性标记,用于胰腺癌的PET成像。方法:两种前体化合物1'-溴乙基-2',3',6',2,3,4,6-庚七-0-乙酰基-β-D-乳糖4和1'-对甲苯磺酰基乙基-2 ',3',6',2,3,4,6-庚七-O-乙酰基-β-D-乳糖5分别通过两个步骤和三个步骤合成;然后,对这些前体进行冷氟化和放射性氟化。使反应混合物通过硅胶Sep-pack柱,用EtOAc和1- [〜18F]氟乙基-2,3,6',2,3,4,6-庚七-O-乙酰基-β洗脱通过HPLC纯化的-D-乳糖([〜18F] -6)。保护基水解后,将1'-[F]氟乙基-β-D-乳糖[〜18F] -7中和,用盐水稀释,通过无菌Millipore过滤器过滤,并通过放射性TLC分析。结果:经衰变校正的平均放射化学产率为9%(n = 7),放射化学纯度> 99%,比活度为55.5 GBq / mumol。结论:已合成了一种新型的乳糖类似物1'-[〜18F]氟乙基-β-D-乳糖,具有较高的纯度和高比活度,适用于早期胰腺癌的PET成像。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号